Home Infusion Therapy Market, By Product Type (Infusion Pumps, Intravenous Set , IV Cannulas , and Needleless Connectors), By Application (Chemotherapy, Diabetes, Hydration Therapy, Pain Management, Post-transplant Therapies, Parenteral Nutrition Therapy, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jun 2024

Code : CMI4276

Pages :193

Formats :

Excel and PDF

Industry : Medical Devices

Key Developments

In January 2023, KORU Medical Systems, Inc. a developer and manufacturer of medical devices, forged a development agreement with a pharmaceutical manufacturer specializing in subcutaneous immunoglobulin therapy (SCIg). The collaboration aims to create and seek regulatory approval for an enhanced version of the Freedom Infusion System featuring a prefilled SCIg syringe. The existing Freedom Infusion System includes the Freddom60 and FreedomEdge Syringe Infusion Drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets, designed for administering infusions in home and alternative care settings.
In September 2022, Baxter International Inc. American multinational healthcare company obtained FDA 510(k) clearance for its Novum IQ syringe infusion pump (SYR) equipped with Dose IQ Safety Software. This development represents Baxter's latest advancement in infusion therapy technology.
In May 2023, Fresenius Kabi, a global healthcare company, entered into an agreement with Premier, Inc., an American healthcare company, resulting in pricing and term advantages for the Ivenix Infusion System. This system aims to enhance the reliability and ease of use of infusion pumps.
Also in May 2023, Option Care Health, a healthcare service provider, partnered with Amedisys Inc., a leading home health services provider, to establish an independent platform for home care services. This platform includes pharmacists, dieticians, therapists, social workers, and other professionals, offering high-quality healthcare services directly at home.
In April 2023, CareFusion, now under Becton Dickinson, an American medical technology company, introduced advanced ultrasound technology designed to improve IV insertions for clinicians. Given that more than 90% of hospitalized patients require IV therapy, this innovation is expected to contribute to the growth of the home infusion therapy market.